HEPATOBLASTOMA
Clinical trials for HEPATOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATOBLASTOMA trials appear
Sign up with your email to follow new studies for HEPATOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: targeted drug shows promise
Disease control OngoingThis study tests an oral drug called cabozantinib in children and young adults (up to age 30) with sarcomas, Wilms tumor, or other rare cancers that have come back or not responded to treatment. The drug works by blocking certain enzymes that help tumors grow and form blood vesse…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New flavored chemo drink aims to ease treatment for kids with hard-to-treat cancers
Disease control OngoingThis early-stage study tests a flavored, drinkable version of the chemotherapy drug irinotecan (VAL-413) combined with another drug (temozolomide) in children and young adults up to age 30 whose solid tumors have come back. The main goal is to find the safest and most effective d…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE1 • Sponsor: Valent Technologies, LLC • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New hope for kids with tough cancers: drug combo trial launches
Disease control OngoingThis study tests a combination of two drugs, cobolimab and dostarlimab, in children and young adults (up to age 21) with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the drugs can shrink tumors. About 83 partici…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Engineered immune cells take aim at childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (up to age 26) with solid tumors that have come back or not responded to standard treatment. The therapy uses the patient's own immune cells, modified to recognize and attack a protein called B…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
New hope for kids with rare liver tumors: tailored therapy trial shows promise
Disease control OngoingThis study tests different treatment plans based on each child's risk level for two rare liver cancers: hepatoblastoma and hepatocellular carcinoma. About 450 children will receive chemotherapy and possibly surgery, with the goal of preventing the cancer from coming back. The app…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
Engineered immune cells take on tough childhood cancers in early trial
Disease control OngoingThis early-phase study tests a personalized cell therapy for children and young adults (ages 1–30) with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells carrying…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC
-
New hope for kids with liver cancer: international trial tests smarter chemo combos
Disease control OngoingThis study tests different combinations of chemotherapy drugs, along with surgery, for children and young adults with two types of liver cancer: hepatoblastoma and hepatocellular carcinoma. The goal is to see which combinations work best to stop tumor growth and improve survival.…
Matched conditions: HEPATOBLASTOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC